Emerging Biotechnology Analyst Breidenbach, along with Dr. Debosch of Washington University, discuss new treatment options for recurrent C. difficile infection on an Analyst/Industry conference call to be held on February 1 at 10 am.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on MCRB:

Tired of arriving late to the Big Returns Party?

Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.

The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.

For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.

Learn More

Disclaimer

More News & Analysis on FNCH

The FlyOppenheimer emerging biotech analyst to hold analyst/industry conference call

2M ago

FNCH

Oppenheimer emerging biotech analyst to hold analyst/industry conference call

FNCH

Finch Therapeutics Announces Decision to Discontinue Phase 3 Trial of CP101 and Focus on Realizing the Value of Its Intellectual Property Estate and Other Assets

FNCH

More FNCH Latest News >

Oppenheimer emerging biotech analyst to hold analyst/industry conference call

More News & Analysis on FNCH

More News & Analysis on FNCH

Latest News Feed